(Q37328038)

19 August 2017

1 reference

title

Percutaneous image-guided therapy of intra-abdominal malignancy: imaging evaluation of treatment response (English)

1 reference

19 August 2017

Debra A Gervais

1

1 reference

19 August 2017

Sanjeeva Kalva

series ordinal

2

1 reference

19 August 2017

Ashraf Thabet

series ordinal

3

1 reference

19 August 2017

publication date

1 September 2009

1 reference

19 August 2017

1 reference

19 August 2017

volume

34

1 reference

19 August 2017

issue

5

1 reference

19 August 2017

page(s)

593-609

1 reference

Renal cell carcinoma: earlier discovery and increased detection

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00261-008-9448-9

Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00261-008-9448-9

Chemoembolization of hepatic neoplasms: safety, complications, and when to worry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00261-008-9448-9

Complications associated with transcatheter arterial embolization for hepatic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00261-008-9448-9

Reduction of metastatic load to liver after intraarterial hepatic yttrium-90 radioembolization as evaluated by [18F]fluorodeoxyglucose positron emission tomographic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00261-008-9448-9

Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00261-008-9448-9

Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00261-008-9448-9

Adverse events during radiofrequency treatment of 582 hepatic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00261-008-9448-9

Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00261-008-9448-9

Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00261-008-9448-9

Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00261-008-9448-9

Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1001/JAMA.299.14.1669

Identifiers

DOI

10.1007/S00261-008-9448-9

1 reference

19 August 2017

1 reference